GenScript
VerifiedGenScript - Make Research Easy - The leader in molecular cloning and gene synthesis, peptide synthesis, protein and antibody engineering..
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$1.1b (Public information from Jul 2024)
Share price
HKD12.54 1548.HK
Piscataway Township New Jersey (HQ)
Deals in current and previous year:
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 43 % | 31 % | 22 % | 34 % | 53 % | 50 % | 45 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (44 %) | (88 %) | (59 %) | (33 %) | (16 %) | 4 % | 14 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (52 %) | (68 %) | (36 %) | (11 %) | (8 %) | 1 % | 14 % |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 67 % | 70 % | 62 % | 52 % | - | - | - |
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $0.0 | round | |
$500m Valuation: $5.9b 15.1x EV/LTM Revenues -34.0x EV/LTM EBITDA | Post IPO Equity | ||
Total Funding | 000k |
Related Content
Recent News about GenScript
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by GenScript
EditACQUISITION by GenScript Dec 2017
ACQUISITION by GenScript Apr 2016